Bladder Cancer
Conditions
Interventions
Experimental group:The patients in the experimental group received neoadjuvant chemotherapy/immune/radiotherapy before surgery and then underwent maximum transurethral resection of bladder tumor (cTUR
Control group:The control group received neoadjuvant chemotherapy followed by radical resection of bladder cancer.
Sponsors
Tianjin Medical University General Hospital
Eligibility
Sex/Gender
Male
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with bladder cancer who underwent surgical treatment at Tianjin Medical University General Hospital; 2. The patients underwent preoperative CT/MRI examination and cystoscopy and obtained histopathology to confirm bladder cancer with indications for radical cystectomy and can tolerate surgical treatment;3. Patients were included in the experimental group for those who refused radical cystectomy or who could not tolerate radical cystectomy, and those who underwent radical cystectomy were included in the control group.
Exclusion criteria
Exclusion criteria: 1. Patients who do not meet the indications for radical surgery of bladder cancer; 2. Patients with bladder cancer are generally in poor condition and cannot tolerate surgery or chemotherapy, immunotherapy, and radiotherapy after evaluation;3. Bladder cancer patients who refuse surgery or chemotherapy, immunotherapy, and radiotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient assessment of quality of life;After the treatment, color Doppler ultrasonography in the experimental group was reviewed every three months, and cystoscopy was performed if necessary. Chest CT, color Doppler ultrasound and the above examinations are performed every six months.;Timely follow-up to assess quality of life, overall survival rate, disease prognosis and progression by using questionnaires or WeChat groups of patients, and salvage treatment if necessary.; | — |
Countries
China
Contacts
Public ContactXiaoqiang Liu
Outcome results
None listed